Advertisement
Screener

CHAMPIONS ONCOLOGY, INC. (CSBR) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

CHAMPIONS ONCOLOGY, INC. Operating Cash Flow

CHAMPIONS ONCOLOGY, INC. (CSBR) reported Operating Cash Flow of -$492.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-09-11

  • CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities for the quarter ending 2026-07-31 was -$492.00K, a 182.00% decline year-over-year.
  • CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities for the quarter ending 2026-04-30 was -$2.00M, a 129.09% decline year-over-year.
  • CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities for the quarter ending 2026-01-31 was -$1.34M, a 373.27% decline year-over-year.
  • CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities for the quarter ending 2025-10-31 was -$1.74M.
  • CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities for fiscal 2026 was -$4.47M, a 160.55% decline from fiscal 2025.
  • CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities for fiscal 2025 was $7.39M.
  • CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$6.14M, a 254.51% decline from fiscal 2023.
  • CHAMPIONS ONCOLOGY, INC. net cash provided by (used in) operating activities for fiscal 2023 was $3.97M, a 38.86% decline from fiscal 2022.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-07-31-$492.00K
10-Q · filed 2026-09-11
-$2.49M
derived: sum of 2 quarters · filed 2026-09-11
-$3.83M
derived: sum of 3 quarters · filed 2026-09-11
-$5.56M
derived: sum of 4 quarters · filed 2026-09-11
2026-04-30-$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27
-$3.34M
derived: sum of 2 quarters · filed 2026-07-27
-$5.07M
derived: sum of 3 quarters · filed 2026-07-27
-$4.47M
10-K · filed 2026-07-27
2026-01-31-$1.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-12
-$3.07M
derived: sum of 2 quarters · filed 2026-03-12
-$2.47M
10-Q · filed 2026-03-12
$4.39M
derived: sum of 4 quarters · filed 2026-09-11
2025-10-31-$1.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15
-$1.14M
10-Q · filed 2025-12-15
$5.73M
derived: sum of 3 quarters · filed 2026-09-11
$6.22M
derived: sum of 4 quarters · filed 2026-09-11
2025-07-31$600.00K
10-Q · filed 2026-09-11
$7.47M
derived: sum of 2 quarters · filed 2026-09-11
$7.96M
derived: sum of 3 quarters · filed 2026-09-11
$7.67M
derived: sum of 4 quarters · filed 2026-09-11
2025-04-30$6.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27
$7.36M
derived: sum of 2 quarters · filed 2026-07-27
$7.08M
derived: sum of 3 quarters · filed 2026-07-27
$7.39M
10-K · filed 2026-07-27
2025-01-31$490.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-12
$207.00K
derived: sum of 2 quarters · filed 2026-03-12
$518.00K
10-Q · filed 2026-03-12
-$1.30M
derived: sum of 4 quarters · filed 2026-03-12
2024-10-31-$283.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15
$28.00K
10-Q · filed 2025-12-15
-$1.79M
derived: sum of 3 quarters · filed 2025-12-15
-$2.71M
derived: sum of 4 quarters · filed 2025-12-15
2024-07-31$311.00K
10-Q · filed 2025-09-15
-$1.50M
derived: sum of 2 quarters · filed 2025-09-15
-$2.42M
derived: sum of 3 quarters · filed 2025-09-15
-$1.83M
derived: sum of 4 quarters · filed 2025-09-15
2024-04-30-$1.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23
-$2.73M
derived: sum of 2 quarters · filed 2025-07-23
-$2.15M
derived: sum of 3 quarters · filed 2025-07-23
-$6.14M
10-K · filed 2025-07-23
2024-01-31-$919.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17
-$330.00K
derived: sum of 2 quarters · filed 2025-03-17
-$4.32M
10-Q · filed 2025-03-17
-$5.01M
derived: sum of 4 quarters · filed 2025-03-17
2023-10-31$589.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-16
-$3.40M
10-Q · filed 2024-12-16
-$4.09M
derived: sum of 3 quarters · filed 2024-12-16
-$2.52M
derived: sum of 4 quarters · filed 2024-12-16
2023-07-31-$3.99M
10-Q · filed 2024-09-13
-$4.68M
derived: sum of 2 quarters · filed 2024-09-13
-$3.11M
derived: sum of 3 quarters · filed 2024-09-13
$176.00K
derived: sum of 4 quarters · filed 2024-09-13
2023-04-30-$692.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-19
$881.00K
derived: sum of 2 quarters · filed 2024-07-19
$4.17M
derived: sum of 3 quarters · filed 2024-07-19
$3.97M
10-K · filed 2024-07-19
2023-01-31$1.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-15
$4.86M
derived: sum of 2 quarters · filed 2024-03-15
$4.66M
10-Q · filed 2024-03-15
$5.46M
derived: sum of 4 quarters · filed 2024-03-15
2022-10-31$3.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-13
$3.09M
10-Q · filed 2023-12-13
$3.89M
derived: sum of 3 quarters · filed 2023-12-13
$8.14M
derived: sum of 4 quarters · filed 2023-12-13
2022-07-31-$195.00K
10-Q · filed 2023-09-13
$601.00K
derived: sum of 2 quarters · filed 2023-09-13
$4.86M
derived: sum of 3 quarters · filed 2023-09-13
$6.09M
derived: sum of 4 quarters · filed 2023-09-13
2022-04-30$796.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-24
$5.05M
derived: sum of 2 quarters · filed 2023-07-24
$6.28M
derived: sum of 3 quarters · filed 2023-07-24
$6.50M
10-K · filed 2023-07-24
2022-01-31$4.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16
$5.49M
derived: sum of 2 quarters · filed 2023-03-16
$5.70M
10-Q · filed 2023-03-16
$3.72M
derived: sum of 4 quarters · filed 2023-03-16
2021-10-31$1.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-13
$1.44M
10-Q · filed 2022-12-13
-$536.00K
derived: sum of 3 quarters · filed 2022-12-13
-$401.00K
derived: sum of 4 quarters · filed 2022-12-13
2021-07-31$216.00K
10-Q · filed 2022-09-12
-$1.76M
derived: sum of 2 quarters · filed 2022-09-12
-$1.63M
derived: sum of 3 quarters · filed 2022-09-12
-$750.00K
derived: sum of 4 quarters · filed 2022-09-12
2021-04-30-$1.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22
-$1.84M
derived: sum of 2 quarters · filed 2022-07-22
-$966.00K
derived: sum of 3 quarters · filed 2022-07-22
-$1.68M
10-K · filed 2022-07-22
2021-01-31$135.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-15
$1.01M
derived: sum of 2 quarters · filed 2022-03-15
$299.00K
10-Q · filed 2022-03-15
$2.84M
derived: sum of 4 quarters · filed 2022-03-15
2020-10-31$879.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-13
$164.00K
10-Q · filed 2021-12-13
$2.71M
derived: sum of 3 quarters · filed 2021-12-13
$2.99M
derived: sum of 4 quarters · filed 2021-12-13
2020-07-31-$715.00K
10-Q · filed 2021-09-13
$1.83M
derived: sum of 2 quarters · filed 2021-09-13
$2.11M
derived: sum of 3 quarters · filed 2021-09-13
$2.47M
derived: sum of 4 quarters · filed 2021-09-13
2020-04-30$2.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26
$2.82M
derived: sum of 2 quarters · filed 2021-07-26
$3.18M
derived: sum of 3 quarters · filed 2021-07-26
$2.90M
10-K · filed 2021-07-26
2020-01-31$279.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-15
$639.00K
derived: sum of 2 quarters · filed 2021-03-15
$360.00K
10-Q · filed 2021-03-15
$612.00K
derived: sum of 4 quarters · filed 2021-03-15
2019-10-31$360.00K
10-Q · filed 2019-12-16
$81.00K
10-Q · filed 2020-12-14
$333.00K
derived: sum of 3 quarters · filed 2020-09-14
$1.54M
derived: sum of 4 quarters · filed 2020-09-14
2019-07-31-$279.00K
10-Q · filed 2020-09-14
-$27.00K
derived: sum of 2 quarters · filed 2020-09-14
$1.18M
derived: sum of 3 quarters · filed 2020-09-14
$1.25M
derived: sum of 4 quarters · filed 2020-09-14
2019-04-30$252.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28
$1.46M
derived: sum of 2 quarters · filed 2020-07-28
$1.53M
derived: sum of 3 quarters · filed 2020-07-28
$1.86M
10-K · filed 2020-07-28
2019-01-31$1.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-16
$1.27M
derived: sum of 2 quarters · filed 2020-03-16
$1.61M
10-Q · filed 2020-03-16
$1.62M
derived: sum of 4 quarters · filed 2020-03-16
2018-10-31$64.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-16
$400.00K
10-Q · filed 2019-12-16
$409.00K
derived: sum of 3 quarters · filed 2019-12-16
$854.00K
derived: sum of 4 quarters · filed 2019-12-16
2018-07-31$336.00K
10-Q · filed 2019-09-16
$345.00K
derived: sum of 2 quarters · filed 2019-09-16
$790.00K
derived: sum of 3 quarters · filed 2019-09-16
$1.06M
derived: sum of 4 quarters · filed 2019-09-16
2018-04-30$9.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29
$454.00K
derived: sum of 2 quarters · filed 2019-07-29
$722.00K
derived: sum of 3 quarters · filed 2019-07-29
-$1.23M
10-K · filed 2019-07-29
2018-01-31$445.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18
$713.00K
derived: sum of 2 quarters · filed 2019-03-18
-$1.24M
10-Q · filed 2019-03-18
-$837.00K
derived: sum of 4 quarters · filed 2019-03-18
2017-10-31$268.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-17
-$1.68M
10-Q · filed 2018-12-17
-$1.28M
derived: sum of 3 quarters · filed 2018-12-17
-$1.97M
derived: sum of 4 quarters · filed 2018-12-17
2017-07-31-$1.95M
10-Q · filed 2018-09-14
-$1.55M
derived: sum of 2 quarters · filed 2018-09-14
-$2.23M
derived: sum of 3 quarters · filed 2018-09-14
-$2.12M
derived: sum of 4 quarters · filed 2018-09-14
2017-04-30$398.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30
-$286.00K
derived: sum of 2 quarters · filed 2018-07-30
-$170.00K
derived: sum of 3 quarters · filed 2018-07-30
-$2.84M
10-K · filed 2018-07-30
2017-01-31-$684.00K
10-Q · filed 2017-03-17
-$568.00K
derived: sum of 2 quarters · filed 2017-03-17
-$3.24M
10-Q · filed 2018-03-19
-$3.56M
derived: sum of 4 quarters · filed 2017-09-14
2016-10-31$116.00K
10-Q · filed 2016-12-14
-$2.56M
10-Q · filed 2017-12-15
-$2.88M
derived: sum of 3 quarters · filed 2017-09-14
-$3.60M
derived: sum of 4 quarters · filed 2017-09-14
2016-07-31-$2.44M
10-Q · filed 2017-09-14
-$2.99M
derived: sum of 2 quarters · filed 2017-09-14
-$3.72M
derived: sum of 3 quarters · filed 2017-09-14
-$6.30M
derived: sum of 4 quarters · filed 2017-09-14
2016-04-30-$555.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28
-$1.28M
derived: sum of 2 quarters · filed 2017-07-28
-$3.87M
derived: sum of 3 quarters · filed 2017-07-28
-$6.41M
10-K · filed 2017-07-28
-$6.45M
10-K · filed 2016-07-29
2016-01-31-$726.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17
-$3.31M
derived: sum of 2 quarters · filed 2017-03-17
-$5.85M
10-Q · filed 2017-03-17
2015-10-31-$2.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14
-$5.13M
10-Q · filed 2016-12-14
2015-07-31-$2.54M
10-Q · filed 2016-09-14
2015-04-30-$9.63M
10-K · filed 2016-07-29
2013-10-31$242.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-13
-$1.90M
10-Q · filed 2013-12-13
-$3.06M
derived: sum of 3 quarters · filed 2013-12-13
-$3.64M
derived: sum of 4 quarters · filed 2013-12-13
2013-07-31-$2.14M
10-Q · filed 2013-09-13
-$3.30M
derived: sum of 2 quarters · filed 2013-09-13
-$3.88M
derived: sum of 3 quarters · filed 2013-09-13
-$4.63M
derived: sum of 4 quarters · filed 2013-12-13
2013-04-30-$1.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26
-$1.74M
derived: sum of 2 quarters · filed 2013-07-26
-$2.49M
derived: sum of 3 quarters · filed 2013-12-13
-$4.29M
10-K · filed 2013-07-26
2013-01-31-$578.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-13
-$1.33M
derived: sum of 2 quarters · filed 2013-12-13
-$3.13M
10-Q · filed 2013-03-13
-$4.66M
derived: sum of 4 quarters · filed 2013-12-13
2012-10-31-$748.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-13
-$2.55M
10-Q · filed 2013-12-13
-$4.08M
derived: sum of 3 quarters · filed 2013-12-13
-$4.49M
derived: sum of 4 quarters · filed 2013-12-13
2012-07-31-$1.81M
10-Q · filed 2013-09-13
-$3.33M
derived: sum of 2 quarters · filed 2013-09-13
-$3.74M
derived: sum of 3 quarters · filed 2013-09-13
-$5.50M
derived: sum of 4 quarters · filed 2013-09-13
2012-04-30-$1.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26
-$1.94M
derived: sum of 2 quarters · filed 2013-07-26
-$3.69M
derived: sum of 3 quarters · filed 2013-07-26
-$5.23M
10-K · filed 2013-07-26
2012-01-31-$413.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-13
-$2.17M
derived: sum of 2 quarters · filed 2013-03-13
-$3.70M
10-Q · filed 2013-03-13
-$4.26M
derived: sum of 4 quarters · filed 2013-03-13
2011-10-31-$1.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-13
-$3.29M
10-Q · filed 2012-12-13
-$3.85M
derived: sum of 3 quarters · filed 2012-12-13
-$2.16M
derived: sum of 4 quarters · filed 2012-12-13
2011-07-31-$1.53M
10-Q · filed 2012-09-12
-$2.09M
derived: sum of 2 quarters · filed 2012-09-12
-$403.00K
derived: sum of 3 quarters · filed 2012-09-12
-$1.15M
derived: sum of 4 quarters · filed 2012-09-12
2011-04-30-$558.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-18
$1.13M
derived: sum of 2 quarters · filed 2012-07-18
$382.00K
derived: sum of 3 quarters · filed 2012-07-18
-$54.00K
10-K · filed 2012-07-18
2011-01-31$1.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-14
$940.00K
derived: sum of 2 quarters · filed 2012-03-14
$504.00K
10-Q · filed 2012-03-14
2010-10-31-$750.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-14
-$1.19M
10-Q · filed 2011-12-14
2010-07-31-$436.00K
10-Q · filed 2011-09-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioStem Technologies, Inc. (BSEM)United States$0.069B
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Vaxart, Inc. (VXRT)United States$0.080B3.84
EXOZYMES INC. (EXOZ)United States$0.058B
BioAtla, Inc. (BCAB)United States$0.058B-0.21
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48